- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03738891
CoolSculpting and EMS for the Abdomen (ECA)
August 14, 2020 updated by: Zeltiq Aesthetics
A Feasibility Study to Evaluate Electromagnetic Muscle Stimulation and CoolSculpting for Abdominal Contouring
Evaluate the use of Electromagnetic Muscle Stimulation as an adjunctive treatment to CoolSculpting.
Study Overview
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Marina Del Rey, California, United States, 90292
- Marina Plastic Surgery
-
Pleasanton, California, United States, 94588
- Innovation Research Center
-
Sacramento, California, United States, 95816
- Laser & Skin Surgery Center of Northern California
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27517
- Aesthetic Solutions, P.A.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
22 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria
- Male and female subjects > 22 years of age and ≤65 years of age.
- Subject has not had weight change exceeding 5% of body weight in the preceding month.
- Subject agrees to maintain her weight (i.e., within 5%) by not making any major changes in diet or exercise routine during the course of the study.
- Subject agrees to refrain from any new abdominal training exercises during the course of the study.
- BMI ≤ 30 kg/m2 as determined at screening.
- Abdominal skin fold thickness 2.0 to 5.0 cm, as measured by caliper below umbilicus.
- Subject has read and signed a written informed consent form.
Exclusion Criteria
- Subject has had a surgical procedure(s) in the area of intended treatment.
- Subject has had an invasive fat reduction procedure (e.g., liposuction, mesotherapy) in the area of intended treatment.
- Subject has had a non-invasive fat reduction, body contouring and/or skin tightening procedure in the area of intended treatment within the past 12 months.
- Subject has numbness, tingling or other altered sensation in the treatment area.
- Subject needs to administer, or has a known history of subcutaneous injections into the area of intended treatment (e.g., heparin, insulin) within the past month.
- Subject has not had an intrauterine contraceptive device inserted or removed within the past month.
- Subject has a known history of cryoglobulinemia, cold urticaria, cold agglutinin disease, or paroxysmal cold hemoglobinuria
- Subject has a known history of Raynaud's disease, or any known condition with a response to cold exposure that limits blood flow to the skin.
- Subject has a history of bleeding disorder or is taking any medication that in the Investigator's opinion may increase the subject's risk of bruising.
- Subject has known sensitivity or allergy to isopropyl alcohol and propylene glycol, or latex.
- Subject is taking or has taken diet pills or supplements within the past month.
- Subject has any dermatological conditions, such as moderate to excessive skin laxity, or scars in the location of the treatment sites, that may interfere with the treatment or evaluation (stretch marks is not an exclusion).
- Subject has a metal implant or active implanted device such as a pacemaker, defibrillator, or drug delivery system.
- Subject has been involved in any type of abdominal muscle training program within the previous 6 months.
- Subject has pulmonary insufficiency.
- Subject has a cardiac disorder.
- Subject has a malignant tumor.
- Subject has been diagnosed with epilepsy.
- Subject currently has a fever.
- Subject is pregnant or intending to become pregnant during the study period (in the next 9 months).
- Subject is lactating or has been lactating in the past 6 months.
- Subject is unable or unwilling to comply with the study requirements.
- Subject is currently enrolled in a clinical study of any other investigational drug or device.
- Any other condition or laboratory value that would, in the professional opinion of the Investigator, potentially affect the subject's response or the integrity of the data or would pose an unacceptable risk to the subject.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Fat Reduction
The treatments are designed to see if the fat can be reduced in the abdomen.
|
The CoolSculpting machine will be used to perform the treatments.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Safety endpoint in relation to adverse events
Time Frame: Final post treatment 1 day visit
|
Measurement of device- or procedure-related adverse events.
|
Final post treatment 1 day visit
|
Effectiveness endpoint gauged by photographs
Time Frame: Final post treatment 1 day visit
|
Comparison of pre-treatment- and 12-week post-final treatment photographs to assess visible changes in the abdomen.
|
Final post treatment 1 day visit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
3-D imaging
Time Frame: Final post treatment 1 day visit
|
Reduction in abdominal circumference as measured by 3-Dimensional imaging.
|
Final post treatment 1 day visit
|
Global Aesthetic Improvement Scale (GAIS)
Time Frame: Final post treatment 1 day visit
|
Subject- graded GAIS at 12-week post-final treatment follow-up.
|
Final post treatment 1 day visit
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Kerrie Jiang, NP, Zeltiq Aesthetics
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 7, 2018
Primary Completion (Actual)
September 9, 2019
Study Completion (Actual)
September 9, 2019
Study Registration Dates
First Submitted
November 8, 2018
First Submitted That Met QC Criteria
November 9, 2018
First Posted (Actual)
November 13, 2018
Study Record Updates
Last Update Posted (Actual)
August 18, 2020
Last Update Submitted That Met QC Criteria
August 14, 2020
Last Verified
August 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ZA18-003
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Body Fat Disorder
-
Zeltiq AestheticsCompleted
-
Zeltiq AestheticsCompleted
-
Zeltiq AestheticsCompleted
-
Zeltiq AestheticsCompleted
-
Zeltiq AestheticsCompletedBody Fat DisorderUnited States
-
Zeltiq AestheticsCompleted
-
Zeltiq AestheticsCompleted
Clinical Trials on The ZELTIQ System
-
Zeltiq AestheticsActive, not recruiting
-
Zeltiq AestheticsUnknown
-
Zeltiq AestheticsCompleted
-
Zeltiq AestheticsCompleted
-
Zeltiq AestheticsUnknown
-
Zeltiq AestheticsCompleted